Cyteir Therapeutics Inc (CYT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CYT Annual Balance Sheets →
Examining balance sheet movements between Cyteir Therapeutics Inc and Sep 30 2022 reveals how Sep 30 2023 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent129.24
Cash & Short-term Investments129.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.40
Total Current Assets130.64
Equipment/Property/Plant Net0.11
Other Assets, Noncurrent0.26
Total Assets131.01
Liabilities
Accounts Payable, Current AC0.51
Other Liabilities, Current5.46
Total Current Liabilities5.97
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
Total Liabilities5.98
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock287.53
Retained Earnings / Accumulated Deficit-162.54
Other Equity0.00
Common Stockholder's Equity125.03
Total Stockholder's Equity125.03
Liabilities & Stockholder's Equity131.01
4 historic quarters locked

Sign in to unlock the full Cyteir Therapeutics Inc balance sheet history.

About Cyteir Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-059370

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.